| (USD) | Sep 2023 | Q/Q |
|---|---|---|
| Revenue | 180.6MM | -2% |
| Gross Profit | 22.6MM | - |
| Cost Of Revenue | 158MM | -0% |
| Operating Income | -42.2MM | -35% |
| Operating Expenses | 222.8MM | -11% |
| Net Income | -82.4MM | -15% |
| Interest Expense | 33.9MM | +9% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Akumin Inc. ("Akumin" or the "Company") (TSX: AKU) announced today that the Toronto Stock Exchange ("TSX") has advised the Company that trading of its common stock will resume on the opening of markets on November 3, 2023. The Company is issuing this press release to provide certain information for its stockholders at the request of the TSX.
Akumin Inc. ("Akumin" or the "Company") (NASDAQ: AKU) (TSX: AKU) announced today that it has reached an agreement with Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, and the Company's stakeholders on the terms of a financial restructuring that will substantially improve the Company's balance sheet and provide ample liquidity to position Akumin for future success. The contemplated transaction will result in Akumin no longer being publicly listed.
Akumin Inc. ("Akumin" or the "Company") (NASDAQ: AKU) (TSX: AKU) announced today that it has changed its auditor from Ernst & Young LLP ("EY") to Deloitte & Touche LLP ("Deloitte").
Akumin Inc. (NASDAQ: AKU) (TSX: AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced today its financial results for the quarter ended June 30, 2023.
Akumin Inc. (NASDAQ/TSX: AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, Thursday, August 10, 2023, to discuss its second quarter 2023 financial results. The financial results are expected to be available on Wednesday, August 9, 2023.
Akumin Inc. ("Akumin" or the "Company") (NASDAQ: AKU) (TSX: AKU) today announced the appointment of Krishna Kumar as President and Chief Operating Officer of the Company, effective as of June 16, 2023.
Akumin Inc. (NASDAQ: AKU) (TSX: AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced today its financial results for the quarter ended March 31, 2023.
Glassbeam, Inc., a pioneer in data and predictive analytics for connected medical machines, today announced that the Glassbeam Board of Directors has appointed Rhonda Longmore-Grund as Chairman of the Board, effective May 1, 2023. Rhonda is shifting to the Chairman role as Eric Milledge transitions to a Board Director position.
Akumin Inc. (NASDAQ: AKU) (TSX: AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, May 11, 2023, to discuss its first quarter 2023 financial results. The financial results are expected to be available on Wednesday, May 10, 2023.
Akumin Inc. (NASDAQ: AKU) (TSX: AKU) ("Akumin" or the "Company"), a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced today its financial results for the quarter and year ended December 31, 2022.